SFlt-1/PlGF ratio as a prognostic marker of adverse outcomes in women with early-onset preeclampsia
Nenhuma Miniatura disponível
Data
2013-07-01
Autores
Oliveira, Leandro Gustavo de [UNESP]
Peraçoli, José Carlos [UNESP]
Peraçoli, Maria Terezinha Serrão [UNESP]
Korkes, Henri
Zampieri, Giafranco
Moron, Antonio F.
Sass, Nelson
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Soluble fms-like tyrosine kinase 1 (sFlt-1) is an anti-angiogenic factor released in higher amounts by preeclamptic placentas and it has been implicated in the endothelial dysfunction observed in the disease. In this study we evaluated if circulating sFlt-1/PlGF ratio is useful to predict adverse outcomes in women with early-onset preeclampsia. This is a cohort study of 88 preeclamptic women with singleton pregnancies at ≤35 weeks of gestation. According to definitions used, adverse outcomes occurred in 46.5% (N = 43) of the patients. The median sFlt1/PlGF ratio (25th-75th centile) for all patients evaluated was of 42.26 (13.1-226.1). The median sFlt-1/PlGF ratio among women who had any adverse outcome (N = 43) versus no adverse outcomes (N = 45) was of 227.6 (80.3-346.1) versus 14.4 (3.35-30.0), (P < 0.0001). According to our analyses a sFlt-1/PlGF ratio cut-point of ≥85 gave a sensitivity of 74.0% and specificity of 97.0%. The positive predictive value and the negative predictive value were 96.0% and 80.0%, respectively. The median sFlt-1/PlGF ratio (25th-75th centile) for patients who delivered within <7 days was 260.0 (127.7-404.7) as compared to 14.4 (3.35-34.97) for those patients who delivered within two weeks or more (P < 0.0001). Our results suggest that sFlt-1/PlGF ratio is a promising marker for adverse outcomes in women with early-onset preeclampsia. © 2013 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.
Descrição
Palavras-chave
Inflammation, PlGF, Preeclampsia, sFlt-1, placental growth factor, vasculotropin receptor 1, adult, Brazil, cohort analysis, controlled study, diagnostic test accuracy study, disease marker, female, gestational age, human, major clinical study, predictive value, preeclampsia, pregnancy outcome, priority journal, prognosis, protein blood level, receiver operating characteristic, sensitivity and specificity
Como citar
Pregnancy Hypertension, v. 3, n. 3, p. 191-195, 2013.